Title : Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer.

Pub. Date : 2020 Jan 31

PMID : 32005679






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The EGFR inhibitor erlotinib decreased CD4+ effector regulatory T cells infiltration in the TME and in combination with anti-PD-1 mAb showed better antitumor effects than either treatment alone. erlotinib epidermal growth factor receptor Homo sapiens